Scilex Holding Co

Scilex Holding Company (Nasdaq: SCLX) is a specialty pharmaceutical company focused on non-opioid and non-addictive pain management products. The company completed its business combination with Vickers Vantage Corp. I, a SPAC sponsored by Vickers Capital Group, in November 2022, bringing it to public markets on Nasdaq. Scilex operates in the specialty pharmaceutical sector, with a commercial portfolio that includes prescription pain-management therapeutics. The company filed an 8-K with the SEC on August 12, 2026 (accession no. 0001193125-26-347186), continuing its regular reporting obligations as a publicly traded registrant. Visit SpacDesk and sign up for a full data subscription to access complete filing histories, deal timelines, and real-time updates on SCLX and hundreds of other SPAC-originated public companies.